SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-15-078466
Filing Date
2015-11-13
Accepted
2015-11-13 07:00:34
Documents
3
Period of Report
2015-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-22960_18k.htm 8-K 20811
2 EX-99.1 a15-22960_1ex99d1.htm EX-99.1 111690
3 GRAPHIC g229601mm01i001.jpg GRAPHIC 3319
  Complete submission text file 0001104659-15-078466.txt   138327
Mailing Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744 512-681-5252
Mirna Therapeutics, Inc. (Filer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37566 | Film No.: 151226883
SIC: 2834 Pharmaceutical Preparations